IPCA Laboratories Limited — Board Meeting, 13-02-2025: Outcome of Board Meeting

Ipca Laboratories has held its board meeting, during which it reviewed and approved its financial results for the third quarter and nine months. The company reported a standalone net total income of ₹1,680.09 Cr, a 10% increase year-over-year, while consolidated net total income rose 9% to ₹2,265.48 Cr. Standalone net profit surged 95% to ₹267.56 Cr, with a consolidated net profit of ₹248.14 Cr, reflecting a 38% increase. The board also noted improvements in EBITDA margins, signaling enhanced operational efficiency.